• 1
    Ferlay J, Bray F, Pisani P, Parkin DM. Globocan 2000: Cancer incidence, mortality and prevalence worldwide [CD-ROM]. Lyon: International Agency for Research on Cancer, 2001.
  • 2
    Parkin DM, Whelan SL, Ferlay J, Teppo L, Thomas DB. Cancer Incidence in Five Continents, Vol. VIII, IARC Scientific Publications No 155. Lyon: International Agency for Research on Cancer, 2002.
  • 3
    Krishnamurthy S, Yecole BB, Jussawalla DJ. Uterine cervical adenocarcinomas and squamous carcinomas in Bombay: 1965–1990. J Obstet Gynaecol Res 1997; 23: 5217.
  • 4
    Saranath D, Khan Z, Tandle AT, Dedhia P, Sharma B, Contractor R, Shrivastava S, Dinshaw K. HPV16/18 prevalence in cervical lesions/cancers and p53 genotypes in cervical cancer patients from India. Gynecol Oncol 2002; 86: 15762.
  • 5
    Clifford GM, Smith JS, Plummer M, Muñoz N, Franceschi S. Human papillomavirus types in invasive cervical cancer worldwide: a meta-analysis. Br J Cancer 2003; 88: 6373.
  • 6
    Capalash N, Sobti RC. Epidemiology of cervical cancer—a case control study on north Indian population. Indian J Cancer 1999; 36: 17985.
  • 7
    Gawande V, Wahab SN, Zodpey SP, Vasudeo ND. Parity as a risk factor for cancer cervix. Indian J Med Sci 1998; 52: 14750.
  • 8
    Biswas LN, Manna B, Maiti PK, Sengupta S. Sexual risk factors for cervical cancer among rural Indian women: a case-control study. Int J Epidemiol 1997; 26: 4915.
  • 9
    Mukherjee BN, Sengupta S, Chaudhuri S, Biswas LN, Maiti P. A case-control study of reproductive risk factors associated with cervical cancer. Int J Cancer 1994; 59: 47682.
  • 10
    Agarwal SS, Sehgal A, Sardana S, Kumar A, Luthra UK. Role of male behavior in cervical carcinogenesis among women with one lifetime sexual partner. Cancer 1993; 72: 16669.
  • 11
    Dutta PK, Upadhyay A, Dutta M, Urmil AC, Thergaonkar MP, Ganguly SS. A case control study of cancer cervix patients attending Command Hospital, Pune. Indian J Cancer 1990; 27: 1018.
  • 12
    Bosch FX, Lorincz A, Muñoz N, Meijer CJ, Shah KV. The causal relation between human papillomavirus and cervical cancer. J Clin Pathol 2002; 55: 24465.
  • 13
    Muñoz N, Franceschi S, Bosetti C, Moreno V, Herrero R, Smith JS, Shah KV, Meijer CJ, Bosch FX. Role of parity and human papillomavirus in cervical cancer: the IARC multicentric case-control study. Lancet 2002; 359: 1093101.
  • 14
    Rajkumar T, Franceschi S, Vaccarella S, Gajalakshmi V, Sharmila A, Snijders PJ, Muñoz N, Meijer CJ, Herrero R. The role of paan chewing and dietary habits in cervical carcinoma in Chennai, India. Br J Cancer 2003; 88: 138893.
  • 15
    Jacobs MV, Walboomers JM, Snijders PJ, Voorhorst FJ, Verheijen RH, Fransen-Daalmeijer N, Meijer CJ. Distribution of 37 mucosotropic HPV types in women with cytologically normal cervical smears: the age-related patterns for high-risk and low-risk types. Int J Cancer 2000; 87: 2217.
  • 16
    Jacobs MV, Roda Husman AM, van den Brule AJ, Snijders PJ, Meijer CJ, Walboomers JM. Group-specific differentiation between high- and low-risk human papillomavirus genotypes by general primer-mediated PCR and two cocktails of oligonucleotide probes. J Clin Microbiol 1995; 33: 9015.
  • 17
    Walboomers JM, Jacobs MV, Manos MM, Bosch FX, Kummer JA, Shah KV, Snijders PJ, Peto J, Meijer CJ, Muñoz N. Human papillomavirus is a necessary cause of invasive cervical cancer worldwide. J Pathol 1999; 189: 129.
  • 18
    Muñoz N, Bosch FX, de Sanjosé S, Herrero R, Castellsagué X, Shah KV, Snijders PJ, Meijer CJ. Epidemiologic classification of human papillomavirus types associated with cervical cancer. N Engl J Med 2003; 348: 51827.
  • 19
    Herrero R, Hildesheim A, Bratti C, Sherman ME, Hutchinson M, Morales J, Balmaceda I, Greenberg MD, Alfaro M, Burk RD, Wacholder S, Plummer M, et al. Population-based study of human papillomavirus infection and cervical neoplasia in rural Costa Rica. J Natl Cancer Inst 2000; 92: 46474.
  • 20
    Molano M, Posso H, Weiderpass E, van den Brule AJ, Ronderos M, Franceschi S, Meijer CJ, Arslan A, Muñoz N. Prevalence and determinants of HPV infection among Colombian women with normal cytology. Br J Cancer 2002; 87: 32433.
  • 21
    Shin HR, Lee DH, Herrero R, Smith JS, Vaccarella S, Hong SH, Jung KY, Kim HH, Park UD, Cha HS, Park S, Touze A, et al. Prevalence of human papillomavirus infection in women in Busan, South Korea. Int J Cancer 2003; 103: 41321.
  • 22
    Barbosa MS, Schlegel R. The E6 and E7 genes of HPV-18 are sufficient for inducing two-stage in vitro transformation of human keratinocytes. Oncogene 1989; 4: 152932.
  • 23
    Burger RA, Monk BJ, Kurosaki T, Anton-Culver H, Vasilev SA, Berman ML, Wilczynski SP. Human papillomavirus type 18: association with poor prognosis in early stage cervical cancer. J Natl Cancer Inst 1996; 88: 13618.
  • 24
    Schwartz SM, Daling JR, Shera KA, Madeleine MM, McKnight B, Galloway DA, Porter PL, McDougall JK. Human papillomavirus and prognosis of invasive cervical cancer: a population-based study. J Clin Oncol 2001; 19: 190615.
  • 25
    Clifford GM, Smith JS, Aguado T, Franceschi S. Comparison of HPV type distribution in high-grade cervical lesions and cervical cancer: a meta-analysis. Br J Cancer, in press.
  • 26
    Schiffman MH, Brinton LA, Devesa SS, Fraumeni JF Jr. Cervical cancer. In: SchottenfeldD, FraumeniJFJr, eds. Cancer epidemiology and prevention, 2nd ed. Oxford: Oxford University Press, 1996. 1090116.
  • 27
    Bayo S, Bosch FX, de Sanjosé S, Muñoz N, Combita AL, Coursaget P, Diaz M, Dolo A, van den Brule AJ, Meijer CJ. Risk factors of invasive cervical cancer in Mali. Int J Epidemiol 2002; 31: 2029.
  • 28
    Brinton LA, Reeves WC, Brenes MM, Herrero R, de Britton RC, Gaitan E, Tenorio F, Garcia M, Rawls WE. Parity as a risk factor for cervical cancer. Am J Epidemiol 1989; 130: 48696.
  • 29
    Parazzini F, Chatenoud L, La Vecchia C, Negri E, Franceschi S, Bolis G. Determinants of risk of invasive cervical cancer in young women. Br J Cancer 1998; 77: 83841.
  • 30
    Thomas DB, Qin Q, Kuypers J, Kiviat N, Ashley RL, Koetsawang A, Ray RM, Koetsawang S. Human papillomaviruses and cervical cancer in Bangkok. II. Risk factors for in situ and invasive squamous cell cervical carcinomas. Am J Epidemiol 2001; 153: 7329.
  • 31
    Muñoz N, Castellsagué X, Bosch FX, Tafur L, de Sanjosé S, Aristizabal N, Ghaffari AM, Shah KV. Difficulty in elucidating the male role in cervical cancer in Colombia, a high-risk area for the disease. J Natl Cancer Inst 1996; 88: 106875.
  • 32
    Balaram P, Sridhar H, Rajkumar T, Vaccarella S, Herrero R, Nandakumar A, Ravichandran K, Ramdas K, Sankaranarayanan R, Gajalakshmi V, Muñoz N, Franceschi S. Oral cancer in southern India: the influence of smoking, drinking, paan-chewing and oral hygiene. Int J Cancer 2002; 98: 4405.
  • 33
    Smith JS, Green J, Berrington A, Appleby P, Peto J, Plummer M, Franceschi S, Beral V. Cervical cancer and use of hormonal contraceptives: a systematic review. Lancet 2003; 361: 115967.
  • 34
    Schultz J. Success of vaccine offers promise of cervical cancer prevention. J Natl Cancer Inst 2003; 95: 1024.